UIM
TXG icon

USS Investment Management’s 10x Genomics TXG Stock Holding History

USS Investment Management’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-26,894
Closed -$1.22M – 692
2022
Q2 		$1.22M Sell
26,894
-772
-3% -$40.1K 0.01% 586
2022
Q1 		$2.11M Buy
27,666
+11,509
+71% +$1.01M 0.02% 569
2021
Q4 		$2.41M Hold
16,157
– – 0.02% 601
2021
Q3 		$2.35M Buy
16,157
+2,277
+16% +$391K 0.02% 604
2021
Q2 		$2.72M Hold
13,880
– – 0.02% 375
2021
Q1 		$2.51M Buy
+13,880
New +$2.4M 0.02% 365

Other funds holding TXG

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
SIM
SRS Investment Management New York $9.47B AUM 60.12% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

USS Investment Management's TXG Position: Q3 2022 in Review

USS Investment Management sold out of 10x Genomics (TXG) in Q3 2022, closing a stake of 26,894 shares — an estimated $1.22M sold.

USS Investment Management first reported a position in TXG in Q1 2021 and held it in 6 quarters. The position peaked at $2.72M in Q2 2021. 233 funds tracked by Wall St. Rank hold TXG as of Q3 2022.

  • USS Investment Management reported no remaining 10x Genomics position as of Q3 2022 after selling out during the quarter.
  • USS Investment Management sold 26,894 10x Genomics shares in Q3 2022, an estimated $1.22M.
  • USS Investment Management first reported a position in 10x Genomics in Q1 2021 and held it in 6 quarters.
  • USS Investment Management's 10x Genomics position peaked at $2.72M in Q2 2021.
  • 233 funds tracked by Wall St. Rank held 10x Genomics as of Q3 2022.

Based on USS Investment Management's 13F filing for Q3 2022, filed 8 Nov 2022.